CG
Christopher Groetsch
Internal Medicine Residency · Lehigh Valley Health Network
Credentials: · ·
History
2026–Present- 2022–2026
Lake Erie College of Osteopathic Medicine
Research
Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial
Cancer Cell · 2024 · 61 citations
1 paper
1 paper
1 paper
1 paper
- DH
1 paper
- HZ
1 paper
1 paper
1 paper
